An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients

Hypereosinophilia (HE) is currently defined by a peripheral blood absolute eosinophil count (AEC) of ≥1,500 cells/microL. Although mild blood eosinophilia (AEC 500–1,500 cells/microL) is observed relatively frequently within the pediatric population, persistent HE is uncommon and should prompt addit...

Full description

Bibliographic Details
Main Authors: Justin T. Schwartz, Patricia C. Fulkerson
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01944/full
id doaj-b2bb599a49ae49d486e5abf8a66c7b4f
record_format Article
spelling doaj-b2bb599a49ae49d486e5abf8a66c7b4f2020-11-24T23:46:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-09-01910.3389/fimmu.2018.01944410757An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric PatientsJustin T. SchwartzPatricia C. FulkersonHypereosinophilia (HE) is currently defined by a peripheral blood absolute eosinophil count (AEC) of ≥1,500 cells/microL. Although mild blood eosinophilia (AEC 500–1,500 cells/microL) is observed relatively frequently within the pediatric population, persistent HE is uncommon and should prompt additional clinical evaluation. While the clinical manifestations and underlying etiologies of HE in adults have been well-characterized, there is a paucity of data on HE in children. Limited evidence suggests that many similarities between adult and pediatric HE likely exist, but some important differences remain between these populations. The evaluation of HE in children can be challenging given the broad differential diagnosis, which includes primary hematologic disorders and secondary eosinophilia in which the increased eosinophil levels are propagated by disease states that promote eosinophil production and survival. On the basis of the underlying etiology, clinical manifestations can range from benign, self-resolving elevations in the AEC to life-threatening disorders with the potential for significant end-organ damage. Given the broad differential diagnosis of HE, it remains essential to systematically approach the evaluation of unexplained HE in children. This review will discuss the differential diagnosis for pediatric HE, highlighting etiologies that are more prevalent within the pediatric population. Additionally, a summary of the epidemiology of pediatric HE will be presented, with focus on some of the differences that exist between pediatric and adult HE. Finally, a directed approach to the diagnostic evaluation of children with HE will be discussed.https://www.frontiersin.org/article/10.3389/fimmu.2018.01944/fullchildreneosinophilhypereosinophiliadifferential diagnosisepidemiologydiagnostic testing
collection DOAJ
language English
format Article
sources DOAJ
author Justin T. Schwartz
Patricia C. Fulkerson
spellingShingle Justin T. Schwartz
Patricia C. Fulkerson
An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients
Frontiers in Immunology
children
eosinophil
hypereosinophilia
differential diagnosis
epidemiology
diagnostic testing
author_facet Justin T. Schwartz
Patricia C. Fulkerson
author_sort Justin T. Schwartz
title An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients
title_short An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients
title_full An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients
title_fullStr An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients
title_full_unstemmed An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients
title_sort approach to the evaluation of persistent hypereosinophilia in pediatric patients
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-09-01
description Hypereosinophilia (HE) is currently defined by a peripheral blood absolute eosinophil count (AEC) of ≥1,500 cells/microL. Although mild blood eosinophilia (AEC 500–1,500 cells/microL) is observed relatively frequently within the pediatric population, persistent HE is uncommon and should prompt additional clinical evaluation. While the clinical manifestations and underlying etiologies of HE in adults have been well-characterized, there is a paucity of data on HE in children. Limited evidence suggests that many similarities between adult and pediatric HE likely exist, but some important differences remain between these populations. The evaluation of HE in children can be challenging given the broad differential diagnosis, which includes primary hematologic disorders and secondary eosinophilia in which the increased eosinophil levels are propagated by disease states that promote eosinophil production and survival. On the basis of the underlying etiology, clinical manifestations can range from benign, self-resolving elevations in the AEC to life-threatening disorders with the potential for significant end-organ damage. Given the broad differential diagnosis of HE, it remains essential to systematically approach the evaluation of unexplained HE in children. This review will discuss the differential diagnosis for pediatric HE, highlighting etiologies that are more prevalent within the pediatric population. Additionally, a summary of the epidemiology of pediatric HE will be presented, with focus on some of the differences that exist between pediatric and adult HE. Finally, a directed approach to the diagnostic evaluation of children with HE will be discussed.
topic children
eosinophil
hypereosinophilia
differential diagnosis
epidemiology
diagnostic testing
url https://www.frontiersin.org/article/10.3389/fimmu.2018.01944/full
work_keys_str_mv AT justintschwartz anapproachtotheevaluationofpersistenthypereosinophiliainpediatricpatients
AT patriciacfulkerson anapproachtotheevaluationofpersistenthypereosinophiliainpediatricpatients
AT justintschwartz approachtotheevaluationofpersistenthypereosinophiliainpediatricpatients
AT patriciacfulkerson approachtotheevaluationofpersistenthypereosinophiliainpediatricpatients
_version_ 1725493877427666944